Log in

M&AFinancial Express

AstraZeneca Pharma India partners with Reliance Industries’ subsidiary Strand Life Sciences

Positive+33

GreyOak summary

AstraZeneca Pharma India signed a Letter of Intent with Strand Life Sciences, a subsidiary of Reliance Industries, to explore collaboration opportunities in India's healthcare sector. The partnership aims to address barriers in timely cancer diagnosis and improve patient outcomes through precision medicine.

What it affects

Source

Read the original at Financial Express

More AstraZeneca Pharma India news

All AstraZeneca Pharma India news →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy